Schedule for the day:

• 9:30 AM - 12:45 PM (with a 15-minute break from 11:00 AM - 11:15 AM): Law & Ethics of the Clinical Use of Artificial Intelligence (AI)
• 12:45 PM - 1:45 PM: 1-hour lunch break
• 1:45 PM - 3:45 PM: Law & Ethics of Psychedelic-Assisted Therapy
• 3:45 PM - 4:00 PM: 15-minute break
• 4:00 PM - 5:00 PM: Emerging Topics and Q&A

Morning Session (9:30 AM - 12:45 PM - includes 15-minute break): Law & Ethics of the Clinical Use of Artificial Intelligence

Description

While new and emerging technologies can provide clinicians with powerful and effective clinical tools, such technologies also have the potential to create a range of new challenges. In this workshop, we will address the specific legal and ethical implications of the use of artificial intelligence (AI) and machine learning in the practice of behavioral health. We will identify and discuss the evolving standards found in federal law, state law, and professional codes of ethics.  Participants will gain the ability to identify and implement a legally and ethically sound approach to evaluating and implementing new AI technologies in clinical practice.

Learning Objectives

After taking part in this training, participants will be able to:

• Identify the emerging ethical standards related to the clinical use of AI
• Apply federal HIPAA standards to the use of AI-powered clinical tools
• Create strategies to effectively evaluate the clinical applicability of new technologies
• Apply legal and ethical standards regarding the use of AI to clinical practice

Lunch Break (12:45 PM - 1:45 PM)

Afternoon Session 1 (1:45 PM - 3:45 PM): Law & Ethics of Psychedelic-Assisted Therapy

Description

This two-hour workshop offers an exploration of the legal and ethical dimensions of psychedelic-assisted therapy (PAT) and a comprehensive overview of the evolving legal and ethical landscape of psychedelic substances used in therapeutic settings.  Participants will gain an understanding of the historical context, current legal status, and regulatory frameworks governing the use of psychedelics in therapy. The course will cover key ethical considerations, including informed consent, patient safety, and potential exposure to liability relating to state and federal controlled substance laws.

Learning Objectives

After taking part in this training, participants will be able to:

• Understand the historical context of psychedelic use in therapy.
• Analyze the current legal status and regulatory issues surrounding PAT.
• Explore ethical considerations associated with PAT.
• Develop strategies for ensuring patient safety and informed consent when conducting PAT.

Afternoon Break (3:45 PM - 4:00 PM)

Afternoon Session 2 (4:00 PM - 5:00 PM): Emerging Topics and Q&A